Menu Search
Equities

Apollo Hospitals Enterprise Ltd

APOLLOHOSP:NSI

Apollo Hospitals Enterprise Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)6,742.50
  • Today's Change48.90 / 0.73%
  • Shares traded258.57k
  • 1 Year change+23.54%
  • Beta1.0133
Data delayed at least 15 minutes, as of Nov 21 2024 10:24 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy6
Outperform13
Hold2
Sell3
Strong Sell0

Share price forecast in INR

The 24 analysts offering 12 month price targets for Apollo Hospitals Enterprise Limited have a median target of 8,050.00, with a high estimate of 8,660.00 and a low estimate of 5,700.00. The median estimate represents a 19.33% increase from the last price of 6,745.95.
High28.4%8,660.00
Med19.3%8,050.00
Low-15.5%5,700.00

Dividends in INR

In 2024, Apollo Hospitals Enterprise Ltd reported a dividend of 16.00 INR, which represents a 6.67% increase over last year. The 17 analysts covering the company expect dividends of 14.75 INR for the upcoming fiscal year, a decrease of 7.80%.
Div growth (TTM)6.67%
More ▼

Earnings history & estimates in INR

On Nov 06, 2024, Apollo Hospitals Enterprise Limited reported 2nd quarter 2025 earnings of 26.34 per share. This result was in line with the consensus of the 4 analysts following the company and exceeded last year's 2nd quarter results by 62.59%.
The next earnings announcement is expected on Feb 06, 2025.
Average growth rate+13.28%
Apollo Hospitals Enterprise Limited reported annual 2024 earnings of 62.62 per share on May 30, 2024.
Average growth rate+92.21%
More ▼

Revenue history & estimates in INR

Apollo Hospitals Enterprise Limited had 2nd quarter 2025 revenues of 55.89bn. This bettered the 55.13bn consensus of the 11 analysts covering the company. This was 26.52% above the prior year's 2nd quarter results.
Average growth rate+3.69%
Apollo Hospitals Enterprise Limited had revenues for the full year 2024 of 190.59bn. This was 14.73% above the prior year's results.
Average growth rate+15.19%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.